SCHEMBL2532446

SCHEMBL2532446

CCOC(=O)c1ccc2c(c1)CC(C)(C)C(c1cccnc1)N2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.47
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 5/20 0.44
GAA P10253 4/20 0.44
CASP1 P29466 3/20 0.44
CASP7 P55210 3/20 0.44
HPGD P15428 3/20 0.44
HSD17B10 Q99714 2/20 0.44
POLB P06746 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
MAPT P10636 3/20 0.43
AR P10275 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.42
PKM P14618 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
GLA P06280 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2531858 0.88 AR (0.52) ALDH1A1KDM4EGAAHPGDHSD17B10
SCHEMBL2531762 0.86 TSHR (0.40) TSHRALDH1A1KDM4EGAAHPGD
SCHEMBL2530589 0.85 SMN1; SMN2 (0.42) TSHRALDH1A1KDM4EGAAHPGD
SCHEMBL2532907 0.84 AR (0.44) TSHRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL2535778 0.83 MAPT (0.44) TSHRALDH1A1KDM4EGAAHPGD
SCHEMBL2535682 0.83 AR (0.43) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL2533356 0.83 SIRT2 (0.42) TSHRALDH1A1KDM4EGAAHPGD
SCHEMBL2535709 0.82 AR (0.41) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL2536543 0.82 AR (0.42) TSHRALDH1A1KDM4EGAAHPGD
SCHEMBL2538431 0.82 AR (0.42) ALDH1A1KDM4EGAAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 TSHR 1338/4885ALDH1A1 552/4885KDM4E 796/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 TSHR 1338/4885ALDH1A1 552/4885KDM4E 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.